Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China

Author:

You Hanxiao1ORCID,Wang Lei1,Wang Jiajia1,Lv Chengyin1,Xu Lingxiao1,Yuan Fenghong2ORCID,Li Ju3,Wu Min4,Zhou Shiliang4,Da Zhanyun5ORCID,Qian Jie5,Wei Hua6,Yan Wei6,Zhou Lei7,Wang Yan7,Yin Songlou8,Zhou Dongmei8,Wu Jian9,Lu Yan10,Su Dinglei11,Liu Zhichun12,Liu Lin13,Ma Longxin14,Xu Xiaoyan15,Zang Yinshan16,Liu Huijie17,Ren Tianli18,Wang Fang19,Zhang Miaojia1,Tan Wenfeng1ORCID

Affiliation:

1. Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University , Nanjing

2. Department of Rheumatology and Immunology, the Affiliated Wuxi People's Hospital of Nanjing Medical University , Wuxi

3. Department of Rheumatology, Huai'an First People's Hospital , Huai'an

4. Department of Rheumatology, The First People's Hospital of Changzhou , Changzhou

5. Department of Rheumatology, Affiliated Hospital of Nantong University , Nantong

6. Department of Rheumatology, Northern Jiangsu People's Hospital , Yangzhou

7. Department of Rheumatology, Changzhou No.2 People's Hospital , Changzhou

8. Department of Rheumatology, The Affiliated Hospital of Xuzhou Medical University , Xuzhou

9. Department of Rheumatology, The First Affiliated Hospital of Soochow University , Suzhou

10. Department of Rheumatology, Jiangsu Province Hospital of Chinese Medicine

11. Department of Rheumatology, Nanjing First Hospital , Nanjing

12. Department of Rheumatology, The Second Affiliated Hospital of Soochow University , Suzhou

13. Department of Rheumatology, Xuzhou Central Hospital , Xuzhou

14. Department of Rheumatology, Yancheng No.1 People's Hospital , Yancheng

15. Department of Rheumatology, Zhongda Hospital Southeast University , Nanjing

16. Department of Rheumatology, The Affiliated Suqian First People's Hospital of Nanjing Medical University , Suqian

17. Department of Rheumatology, The First People's Hospital of Lianyungang , Lianyungang

18. Department of Rheumatology, Wuxi No.2 People's Hospital , Wuxi

19. Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, China , Nanjing, Jiangsu, China

Abstract

Abstract Objectives Anti-melanoma differentiation-associated gene 5 positive (anti-MDA5+) DM has a close relationship with rapidly progressive interstitial lung disease (RPILD) and is associated with high mortality. However, data regarding the time-dependent risk of RPILD and deaths during disease progression are limited. We conducted this study to investigate whether the risk of RPILD and death were time-dependent or not in anti-MDA5+ DM. Methods We assessed a cohort of 272 patients with anti-MDA5+ DM. The clinical characteristics of patients with anti-MDA5+ were collected, and COX regression was used to analyse independent risk factors for RPILD and death. We also described changes in risk of RPILD and death over time and their potential clinical implications. Results There were 272 anti-MDA5+ DM patients enrolled in this study. According to the multivariate cox regression analysis, short disease course, high CRP level, anti-Ro52 positive and anti-MDA5 titre (++∼+++) were independent risk factors of RPILD. High creatine kinase level, high CRP level and RPILD were independent risk factors for death, and >90% RPILD and 84% mortality occurred in the first 6 months after disease onset. Notably, the first 3 months is a particularly high-risk period, with 50% of RPILD and 46% of deaths occurring. Hazards regarding RPILD and mortality diminished over time during a median follow-up of 12 months. Conclusion These results suggest significant, time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients, providing a cut-off time window to estimate disease progression and poor prognosis.

Funder

National Natural Science Foundation of China

NSFC

China Postdoctoral Science Foundation

Natural Science Foundation of Jiangsu Province

Doctoral Program of Entrepreneurship and Innovation in Jiangsu Province

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Reference36 articles.

1. Interstitial lung disease in anti-MDA5 positive dermatomyositis;Wu;Clin Rev Allergy Immunol,2021

2. Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies;Cavagna;Clin Exp Rheumatol,2022

3. Pharmacologic treatment of Anti-MDA5 rapidly progressive interstitial lung disease;Selva;Curr Treatm Opt Rheumatol,2021

4. Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the FLAIR model;Lian;Chest,2020

5. Antimelanoma differentiation-associated gene 5 antibody: expanding the clinical spectrum in North American patients with dermatomyositis;Moghadam-Kia;J Rheumatol,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3